Established molecular biomarkers currently identified include those related to receptor status such as estrogen receptors (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2); the proliferation marker, Ki67, and other markers including the genomic grade index and tumor-infiltrating lymphocytes [4]. The gene discussed is PGR; the disease is neoplasm.